ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för naltrexone. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

24 träffar

Bibliografisk träff 2017-02-18

A SMART data analysis method for constructing adaptive treatment strategies for substance use disorders.

Nahum-Shani I, Ertefaie A, Lu XL, Lynch KG, McKay JR, Oslin DW, Almirall D.

Addiction · research-article; journal article · DOI 10.1111/add.13743

Bibliografisk träff 2017-02-17

Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone.

Naik S, Belfort-DeAguiar R, Sejling AS, Szepietowska B, Sherwin RS.

Diabetes Obes Metab · research-article; randomized controlled trial; journal article · DOI 10.1111/dom.12855

Bibliografisk träff 2017-02-08

Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.

Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, Oden NL, Lindblad R, Sorensen JL, Arenas V, Ha D, Mandler RN, McCarty D, CTN-0055 CHOICES Investigators.

Addiction · research-article; randomized controlled trial; journal article · DOI 10.1111/add.13753

Bibliografisk träff 2017-02-07

Effect of combined opioid receptor and α<sub>2</sub>-adrenoceptor blockade on anxiety and electrically evoked startle responses.

Vo L, Drummond PD.

J Psychopharmacol · research support, non-u.s. gov't; journal article · DOI 10.1177/0269881116689259

Bibliografisk träff 2017-02-03

Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.

Jarvis BP, Holtyn AF, DeFulio A, Dunn KE, Everly JJ, Leoutsakos JS, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.

Addiction · research-article; journal article · DOI 10.1111/add.13724

Bibliografisk träff 2017-02-01

Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice.

Moslehi A, Nabavizadeh F, Zekri A, Amiri F.

Clin Exp Pharmacol Physiol · journal article · DOI 10.1111/1440-1681.12695

Bibliografisk träff 2017-01-31

A combined opiate agonist and antagonist treatment reduces prolactin secreting pituitary tumor growth.

Maglakelidze G, Wynne O, Sarkar DK.

J Cell Commun Signal · research-article; journal article · DOI 10.1007/s12079-017-0374-x

Bibliografisk träff 2017-01-30

Accelerated in vitro release testing method for naltrexone loaded PLGA microspheres.

Andhariya JV, Choi S, Wang Y, Zou Y, Burgess DJ, Shen J.

Int J Pharm · journal article · DOI 10.1016/j.ijpharm.2017.01.050

Bibliografisk träff 2017-01-27

Advances in the treatment of opioid use disorders.

Woody GE.

F1000Res · review-article; review; journal article · DOI 10.12688/f1000research.10184.1

Bibliografisk träff 2017-01-24

Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion/Naltrexone (Contrave<sup>®</sup>).

Singh PA, Cassel KP, Moscati RM, Eckersley D.

J Emerg Med · journal article; case reports · DOI 10.1016/j.jemermed.2016.11.034

Bibliografisk träff 2017-01-20

Naltrexone for the treatment of comorbid tobacco and pornography addiction.

Capurso NA.

Am J Addict · journal article; case reports · DOI 10.1111/ajad.12501

Bibliografisk träff 2017-01-10

Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.

Sullivan M, Bisaga A, Pavlicova M, Choi CJ, Mishlen K, Carpenter KM, Levin FR, Dakwar E, Mariani JJ, Nunes EV.

Am J Psychiatry · comparative study; research-article; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.1176/appi.ajp.2016.16050548

Bibliografisk träff 2016-12-24

Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study.

Jarvis BP, DeFulio A, Long L, Holtyn AF, Umbricht A, Fingerhood M, Bigelow GE, Silverman K.

J Subst Abuse Treat · research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.jsat.2016.12.006

Bibliografisk träff 2016-12-23

Computation-Assisted Molecularly Imprinted Polymer Synthesis for Extraction of Naltrexone from Urine Using Experimental Design and Determination by UPLC-DAD.

Rahmani ME, Ansari M, Nateghi M, Kazemipour M.

J AOAC Int · journal article · DOI 10.5740/jaoacint.16-0226

Bibliografisk träff 2016-12-20

Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.

Gordon MS, Vocci FJ, Fitzgerald TT, O'Grady KE, O'Brien CP.

Contemp Clin Trials · research-article; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.1016/j.cct.2016.12.015

Bibliografisk träff 2016-11-24

Naltrexone-Associated Acute Pancreatitis.

Verma R.

Prim Care Companion CNS Disord · letter; case reports · DOI 10.4088/pcc.16l01953

Bibliografisk träff 2016-11-03

Urgency traits moderate daily relations between affect and drinking to intoxication among young adults.

Bold KW, Fucito LM, DeMartini KS, Leeman RF, Kranzler HR, Corbin WR, O'Malley SS.

Drug Alcohol Depend · research-article; randomized controlled trial; journal article · DOI 10.1016/j.drugalcdep.2016.10.035

Bibliografisk träff 2016-11-01

Guidelines and Quality Measures Should Reflect Evidence for Effectiveness of Naltrexone.

Fiscella K.

J Addict Med · comment; journal article · DOI 10.1097/adm.0000000000000265

Bibliografisk träff 2016-10-17

An update on naltrexone/bupropion extended-release in the treatment of obesity.

Saunders KH, Igel LI, Aronne LJ.

Expert Opin Pharmacother · journal article · DOI 10.1080/14656566.2016.1244527

Bibliografisk träff 2016-10-01

Daily relations among affect, urge, targeted naltrexone, and alcohol use in young adults.

Bold KW, Fucito LM, Corbin WR, DeMartini KS, Leeman RF, Kranzler HR, O'Malley SS.

Exp Clin Psychopharmacol · research-article; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.1037/pha0000090

Bibliografisk träff 2016-08-07

Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats.

Ghiassy B, Rahimi N, Javadi-Paydar M, Gharedaghi MH, Norouzi-Javidan A, Dehpour AR.

Can J Physiol Pharmacol · journal article · DOI 10.1139/cjpp-2016-0188

Bibliografisk träff 2014-03-21

Naltrexone metabolism and concomitant drug concentrations in chronic pain patients.

Liu JC, Ma JD, Morello CM, Atayee RS, Best BM.

J Anal Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1093/jat/bku019

Bibliografisk träff 2013-09-20

Phase I study of injectable, depot naltrexone for the relapse prevention treatment of opioid dependence.

Xuyi W, Juelu W, Xiaojun X, Haiyan L, Zheyuan L, Zhehui G, Guoming D, Gang L, Jin L, Wei H.

Am J Addict · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1111/j.1521-0391.2013.12085.x

Bibliografisk träff 2006-10-01

Emergency naloxone for heroin overdose: naloxone is not the only opioid antagonist.

Brewer C.

BMJ · letter; comment · DOI 10.1136/bmj.333.7571.754-b